Main menu

Building capacity for public health bioinformatics in East Africa using a portable sequencing platform

George’s work aims to build capacity in viral outbreak surveillance and real-time portable nanopore sequencing, based on regional priorities.

George’s ‘Nanopore journey’ has developed over 4 or 5 yrs, with current focuses on metagenomic assays, amplicon sequencing of measles and rubella, and SARS-CoV-2.

They sequenced SARS-CoV-2 first in April 2020, shortly after the 1st Kenyan case was identified. ‘Now we have about 120 genomes that we have sequenced’.

Phylogenetic monitoring of SARS-CoV-2 in Kenya: from initial importation via international travel, now to local transmission.

resources.authors: George Githinji

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag